Biotech · Private company
Evergreen Therapeutics, Inc.
Track this companyFree. Adds Evergreen Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- EG-501Phase 2 · Neuropsychiatric Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT03527472 · fetched Nov 12, 2026
- EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety StudyPHASE2 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT07281105 · fetched Nov 12, 2026